Neuphoria Therapeutics (BNOXN) Ownership - Who Owns Neuphoria Therapeutics?
Neuphoria Therapeutics (BNOXN) Ownership Overview
- 4.20% Mutual Funds
- 25.84% Other Institutional Investors
- 8.58% ETFs
- 61.39% Public Companies and Individual Investors
The ownership structure of Neuphoria Therapeutics (MX:BNOXN) stock is a mix of institutional, retail, and individual investors. Approximately 38.61% of the company’s stock is owned by Institutional Investors, and 61.39% is owned by Public Companies and Individual Investors.
The ownership structure of Neuphoria Therapeutics (MX:BNOXN) stock is a mix of institutional, retail, and individual investors. Approximately 38.61% of the company’s stock is owned by Institutional Investors, and 61.39% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Oct 22, 2025 | Lynx1 Capital Management Lp | $3,278,634 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Advisorshares | 290,653 | Institution | 5.37% | ― |
| Vanguard | 173,488 | Institution | 3.21% | ― |
| Vanguard Index Funds | 173,488 | Institution | 3.21% | ― |
| Fidelity Concord Street Trust | 53,579 | Institution | 0.99% | ― |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 173,488 | Institution | 3.21% | ― |
| Fidelity Concord Street Trust | 53,579 | Institution | 0.99% | ― |
FAQ
What percentage of Neuphoria Therapeutics (MX:BNOXN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.61% of Neuphoria Therapeutics (MX:BNOXN) stock is held by institutional investors: 4.20% by mutual funds, 8.58% by ETFs and 25.84% by other institutional investors.
What percentage of Neuphoria Therapeutics (MX:BNOXN) stock is held by retail investors?
According to the latest TipRanks data, approximately 61.39% of Neuphoria Therapeutics (MX:BNOXN) stock is held by public companies and individual investors.
Who owns the most shares of Neuphoria Therapeutics (MX:BNOXN)?
AdvisorShares owns the most shares of Neuphoria Therapeutics (MX:BNOXN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
